U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
1 year ago
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE:
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an
The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences’ (NASDAQ: KZR) trial of an
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
SAO PAULO – Novo Nordisk (NYSE: NVO), a Danish drugmaker, will invest 864 million reais ($158.2 million) to revamp a
One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific (NYSE: TMO) over the
On Friday, Recordati, the Italian pharma group, said it would buy from Sanofi (NASDAQ: SNY) the global rights to a
Humana (NYSE: HUM) shares fell as much as 22.4% on Wednesday, as the health insurer said enrollments in its top-rated
On Tuesday, Novo Nordisk (NYSE: NVO), a Danish drugmaker, said it has mitigation plans in place to minimize or prevent
Health insurers Cigna (NYSE: CI), CVS Health (NYSE: CVS), Humana (NYSE: HUM), and Centene (NYSE: CNC) on Tuesday released details
